Quantcast
Last updated on April 18, 2014 at 13:27 EDT

Fujifilm’s Aspire HD Receives FDA Clearance

September 12, 2011

STAMFORD, Conn., Sept. 12, 2011 /PRNewswire/ – Breast Imaging facilities looking for increased diagnostic confidence in mammography screening can now benefit from the exceptional image quality of the Aspire(TM) HD Full Field Digital Mammography (FFDM) system from FUJIFILM Medical Systems U.S.A., Inc. Now FDA 510(k) cleared, the Aspire HD provides image clarity that enables extraordinary detail of potential abnormalities that not only assists in more accurate and reliable diagnoses, but also results in enhanced clinician productivity.

(Photo: http://photos.prnewswire.com/prnh/20110316/NY65935)

The exceptional image quality of the Aspire HD is made possible in part by the system’s unique proprietary detector that uses innovative dual layer amorphous selenium (a-Se) and the first use of Fujifilm’s innovative Direct Optical Switching (DOS) technology. This new technology combined with the company’s renowned 50-micron resolution provides facilities with the confidence they need for the detailed visualization that’s required in mammography.

“Breast imaging facilities and their patients deserve the latest and most reliable technologies,” says David Hotchkiss, Director, Product Marketing, Modality Solutions for Fujifilm. “As we build upon our proven technological foundation for mammography, Fujifilm will continue to provide exceptional image quality that will raise the bar for performance and reliability in breast screening.”

The new DOS technology eliminates the use of Thin Film Transistors (TFTs) which are currently used in typical FFDM detector systems. By eliminating the TFTs, this new technology creates a direct image transfer that results in a higher efficiency image capture. This process produces images with less noise and the potential to reduce dose, while delivering the performance and reliability digital mammography users have come to expect from Fujifilm.

Fujifilm is the world leader in FFDM with more than 8000 systems installed worldwide. The company was the first to bring computed radiography- (CR) based FFDM to the U.S. market in 2006 and has been successfully serving the needs of hospitals and imaging centers with the Aspire ClearView-CSm and the Aspire ClearView-1m, multi- and single-imaging plate systems with Image Intelligence(TM), Fujifilm’s proprietary image processing technology.

“Now that Aspire HD has FDA clearance, Fujifilm is the first and only vendor to provide both CR-and DR-based FFDM systems in the U.S., assuring that we have a solution that is right for any and every facility’s needs,” concludes Hotchkiss. “The addition of the new DR based system to our product portfolio further establishes Fujifilm as an integrated x-ray room provider.”

For more information about Fujifilm’s Aspire HD FFDM system, please visit Aspire.fujimed.com.

About Fujifilm

FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of diagnostic imaging products and medical informatics solutions to meet the needs of healthcare facilities today and well into the future. From a wide selection of digital x-ray systems, to the Synapse® brand of PACS, RIS and cardiovascular products, to advanced women’s health imaging systems, Fujifilm has products that are ideal for any size imaging environment. FUJINON is a subsidiary of FUJIFILM Medical Systems U.S.A., Inc., and supplies technologically advanced endoscopes to the medical market. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Stamford, CT. For more information visit www.fujimed.com.

FUJIFILM Holdings Corporation, Tokyo, Japan, brings continuous innovation and leading-edge products to a broad spectrum of industries, including electronic imaging, digital printing equipment, medical systems, life sciences, graphic arts, flat panel display materials, and office products, based on a vast portfolio of digital, optical, fine chemical and thin film coating technologies. The company was among the top 16 companies around the world granted U.S. patents in 2010, and in the year ended March 31, 2011, had global revenues of $25.8 billion*. Fujifilm is committed to environmental stewardship and good corporate citizenship. For more information, please visit www.fujifilmholdings.com.

* At an exchange rate of 86 yen to the dollar.

© 2011 FUJIFILM Medical Systems U.S.A., Inc.

SOURCE FUJIFILM Medical Systems U.S.A., Inc.


Source: PR Newswire